This stresses the importance of HGF paracrine/endocrine function in MET mutant tumours that is involved in angiogenesis, growth, migration and invasion (Shojaei et al, 2010) and the potential role of MET inhibitors in cases with MET mutations. This evidence concerns the gene MET and neoplasm.